StockWatch
·
Q2 FY-2027 RESULTS · RALLIS

Rallis India Q2 FY27: PAT Falls 17% YoY to ₹85 Cr as Margins Compress, Misses Preview

PAT -16.7% YoY · revenue -0.3% · margins compressing · miss vs street

Q2 FY27 resultsRALLISRALLIS INDIA LTD.22 Oct 2026 · 3 min read
Revenue

₹858 Cr

-0.3% YoY

PAT (standalone)

₹85 Cr

-16.7% YoY

Net margin

9.82%

-1.9pp YoY

EPS

₹4.37

Rallis India's standalone Q2 FY27 (quarter ended September 30, 2026) print was weak on a year-on-year basis — the primary lens here, since the business is explicitly flagged as seasonal and monsoon/cropping-pattern dependent. Revenue from operations was effectively flat at ₹858 Cr versus ₹861 Cr a year ago (-0.3%), while net profit fell 16.7% YoY to ₹85 Cr from ₹102 Cr. The reported decline actually understates the underlying weakness: this quarter carried a ₹14 Cr exceptional gain (profit on sale of flats/freehold land) versus a smaller ₹6 Cr equivalent gain in the year-ago quarter. Stripping both one-offs out and applying each period's own effective tax rate, adjusted PAT works out to roughly ₹75 Cr versus ₹98 Cr a year ago — a ~23.6% adjusted YoY decline, meaningfully worse than the 16.7% reported figure. Sequentially, revenue fell 16.1% and PAT fell 32.0% from Q1 FY27's ₹1,022 Cr / ₹125 Cr, but Q1 (the kharif-season quarter) is seasonally the strongest for an agri-inputs business, so this QoQ drop is a seasonality artifact rather than a trend break and should not be read as fresh weakness.

The scoreboard

Q2 FY-2027 vs prior quarters

Standalone P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹858 Cr-16%-0.3%
Expenses₹766 Cr-11.9%+3.5%
PAT₹85 Cr-32%-16.7%
Net margin9.82%-2.3pp-1.9pp
EPS₹4.37-32%-16.4%

Margins compressed on both comparisons. Net profit margin (on total income) fell to 9.8% from 11.7% a year ago and 12.1% in Q1 FY27. On an EBITDA basis (revenue less operating costs, adding back depreciation and finance costs), margin fell to roughly 14.7% from ~17.9% YoY and ~18.1% QoQ — compression of 320-340bps either way. The squeeze sits mainly in cost of materials and stock-in-trade purchases, which rose faster than revenue even as the company unwound part of Q1's inventory build. Employee costs (₹69 Cr) also normalized upward from Q1's unusually low ₹52 Cr, which had benefited from a one-time ₹35 Cr reversal of performance-incentive and retiral provisions tied to salary-structure harmonisation — a reversal that did not recur in Q2, flattering the QoQ margin base further.

₹
190.47204.14217.82231.49245.1620407-2008-1109-0209-2510-2110-22Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹204, up 0.9% over the past month of trading.

₹ Cr
-31.826.0783.93141.895Q1 FY26rev ₹957 Cr102Q2 FY26rev ₹861 Cr2Q3 FY26rev ₹623 Cr-15Q4 FY26rev ₹456 Cr125Q1 FY27rev ₹1,022 Cr85Q2 FY27rev ₹858 Cr
Quarterly standalone PAT, ₹ Crore
Beyond the headline

What the summary numbers don't show

SBI Mutual Fund sold a 2% stake (Sept 12) and CFO Bhaskar Swaminathan is set to step down Nov 4, 2026 — two overhangs to track into Q3.

What management guided (1 FY-2027 call)
FY27 agrochemical industry growth 6-8%; seeds mid-to-high single digits (excluding cotton). Company pursuing market share from unorganized players. Margins guided stable-to-soft; pricing power limited mid-season. Rabi/kharif volume recovery dependent on rainfall.

— This quarter: missed

Management's July 2026 guidance had called for FY27 agrochemical industry growth of 6-8% and seeds growth in the mid-to-high single digits, with margins "stable-to-soft" and volume recovery contingent on monsoon quality and limited mid-season pricing power. This quarter's flat revenue and 320-390bps margin compression sit below that growth guidance and at the weak end of the margin call, so the print reads as a miss against management's own framing. It also missed Rallis's own pre-result preview, which had expected revenue of ₹900-950 Cr, PAT of ₹100-110 Cr and EBITDA margin of 17-18% — actuals of ₹858 Cr, ₹85 Cr and ~14.7% landed below every band. No verified third-party consensus estimate specific to this quarter could be confirmed via web search; the Street's pre-result stance was already cautious-to-mixed per our preview (price targets spanning ₹179-369 with a split hold/sell/buy rating mix), and this result gives no reason to resolve that disagreement toward the bullish end.

  • W1

    Volume/revenue recovery versus management's guided FY27 agrochemical industry growth of 6-8% (seeds mid-to-high single digits) — this quarter printed -0.3% YoY, well below that band.

  • W2

    EBITDA margin trajectory from ~14.7% this quarter — whether the ₹35 Cr Q1 cost-reversal benefit (salary-structure harmonisation) recurs or margins stay at the lower H2 base.

  • W3

    CFO transition completing November 4, 2026, and continuity of financial reporting/guidance cadence into Q3 FY27.

Informational and educational content only. Not investment advice.